Dr. Sadiq is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7910 W Jefferson Blvd
Ste 108
Fort Wayne, IN 46804Phone+1 260-484-8830Fax+1 260-483-1911
Education & Training
- University of ChicagoFellowship, Hematology and Medical Oncology, 2010 - 2013
- Texas Tech University (Amarillo)Residency, Internal Medicine, 2004 - 2007
- Brooklyn Hospital CenterInternship, Transitional Year, 2003 - 2004
- King Edward Medical UniversityClass of 2000
Certifications & Licensure
- IN State Medical License 2013 - 2025
- IL State Medical License 2010 - 2014
- MN State Medical License 2007 - 2011
- TX State Medical License 2006 - 2009
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2014
Publications & Presentations
PubMed
- 982 citationsAtezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-...Howard Jack West, Michael McCleod, Maen A. Hussein, Alessandro Morabito, Achim Rittmeyer
The Lancet. Oncology. 2019-07-01 - 85 citationsA phase 2 trial of consolidation pembrolizumab following concurrent chemoradiation for patients with unresectable stage III non–small cell lung cancer: Hoosier cancer ...Greg Andrew Durm, Salma K. Jabbour, Sandra Althouse, Ziyue Liu, Ahad Ali Sadiq
Cancer. 2020-10-01 - 10 citations4EGI-1 represses cap-dependent translation and regulates genome-wide translation in malignant pleural mesothelioma.Arpita De, Blake A. Jacobson, Mark S. Peterson, Joe Jay-Dixon, Marian G. Kratzke
Investigational New Drugs. 2018-04-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: